Tissue recovery practices and bioburden: a systematic review

S Brubaker1, K Lotherington2, Jie Zhao3

  • 1American Association of Tissue Banks, 8200 Greensboro Drive, Suite 320, Mclean, VA, 22102, USA.

Cell and Tissue Banking
|October 21, 2016
PubMed

Insights

Minimizing tissue contamination during recovery is crucial for successful transplantation. Factors like recovery time and personnel experience impact bioburden, but more evidence-based data is needed to confirm effective contamination control methods.

Area of Science:

  • Transplantation Science
  • Microbiology
  • Public Health

Background:

  • Allograft transplantation success depends on microbial-free tissues to prevent recipient harm.
  • Tissue contamination can occur during recovery or processing, posing risks to transplant recipients.
  • Current understanding of contamination control during tissue recovery is limited by heterogeneous practices.

Purpose of the Study:

  • To identify factors influencing microbial contamination rates during tissue allograft recovery.
  • To evaluate the effectiveness of various tissue recovery methods in controlling bioburden.
  • To highlight the need for evidence-based data on contamination control in tissue recovery.

Main Methods:

  • Review of factors affecting tissue contamination rates during recovery.
  • Analysis of recovery parameters including time post-mortem, personnel experience, and recovery site.
  • Examination of skin preparation efficacy and technical recovery procedures.

Main Results:

  • Minimizing recovery times (e.g., <24 hours post-mortem) and using experienced personnel can reduce contamination.
  • Factors such as time to recovery post-asystole, total recovery duration, recovery site, skin preparation, and technical procedures may influence contamination.
  • The impact of additional barriers and hygienic precautions on bioburden remains inconclusive due to varied practices.

Conclusions:

  • Several factors during tissue recovery can influence microbial contamination rates.
  • There is a significant lack of qualified studies and evidence-based data to support specific methods for reducing bioburden.
  • Further research is required to establish standardized, effective protocols for minimizing contamination in tissue allograft recovery.